Video
- Author:
- Amy Karon
Publish date: February 1, 2018
Blood levels of mercury, lead, and cadmium were significantly higher in those who followed a gluten-free diet.
News
- Author:
- Amy Karon
Publish date: February 1, 2018
In a study of 102 patients, one in five with remitted Crohn’s disease developed a major complication after withdrawing from infliximab.
News
- Author:
- Amy Karon
Publish date: February 1, 2018
Most of these cysts were “indolent and dormant,” but some grew rapidly and developed “other worrisome features.”
News
- Author:
- Amy Karon
Publish date: January 23, 2018
Liver stiffness decreased after patients achieved sustained virologic response.
News
- Author:
- Amy Karon
Publish date: January 3, 2018
ATLANTA – Don’t wait to give anticytokine therapy.
News
- Author:
- Amy Karon
Publish date: January 2, 2018
Preliminary data suggest a rapid hematologic response after one dose of daratumumab and high rates of response at 3 and 6 months.
News
- Author:
- Amy Karon
Publish date: December 27, 2017
For young Hispanic patients with myeloma, 5-year survival improved from 39% before 1996 to 56% from 2002 onward, a insignificant difference.
News
- Author:
- Amy Karon
Publish date: December 26, 2017
ATLANTA – Daratumumab monotherapy led to durable partial responses among intermediate to high-risk patients with smoldering multiple myeloma.
News
- Author:
- Amy Karon
Publish date: December 26, 2017
ATLANTA – Successfully treating Waldenström macroglobulinemia often resolves acquired von Willebrand disease.
News
- Author:
- Amy Karon
Publish date: December 19, 2017
ATLANTA - Caplacizumab led to significantly faster platelet normalization and lower recurrence rates in acquired thrombotic thrombocytopenic purpur...
News
- Author:
- Amy Karon
Publish date: December 12, 2017
ATLANTA – Phase 2 data on aTTP earned caplacizumab an FDA fast track designation in July 2017.
News
- Author:
- Amy Karon
Publish date: December 12, 2017
ATLANTA – Twelve months of daily edoxaban was noninferior to subcutaneous therapy with dalteparin for VTE in patients with cancer.
News
- Author:
- Amy Karon
Publish date: December 12, 2017
Findings suggest that a stepwise treat-to-target strategy can prevent overtreatment in about one in four patients with early RA.
News
- Author:
- Amy Karon
Publish date: December 11, 2017
ATLANTA – A quarter of the patients in the study were infused as outpatients.
News
- Author:
- Amy Karon
Publish date: December 10, 2017
ATLANTA – Mogamulizumab topped vorinostat in terms of overall response to treatment and on several quality of life scales
